More articles from Volume 28, Issue 2, 2012
Reactive lymphadenopathy in daily practice
Diffuse large B cell lymphoma: variants, subgroups and subtypes/entities
Problematic 'low grade' lesions in lymphoproliferative pathology
Problematic 'high grade' lesions in lymphoproliferative pathology
Classical Hodgkin lymphoma: Differential diagnosis and tumour microenvironment
Article views
NOVINE U PaTOLOGIjI/NEWs IN PaTHOLOGY Endomyocardial biopsy: yesterday, today and tomorrow
Jovan Vasiljevic
Published: 01.12.2011.
Biochemistry
Volume 28, Issue 2 (2012)
pp. 548-563;
Abstract
Keywords
References
1.
The endomyocardial biopsy revisited (Editorial). Mayo Clin Proc. 1990;1506–9.
2.
1986;289–99.
3.
Konno S. 1962;537–41.
4.
Richardson Pj. King’s endomyocardial biopsy. Lancet. 1974;660.
5.
1983;15–23.
6.
Mills, Thompson J, Hess M. Expectations and limitaions of endomyocardial biopsy in cardiomyopathy. Can j Cardiol. 1985;358–62.
7.
Van Fossen Db. Morbidity of endomyocardial biopsy in cardiomyopathy. am j Cardiol. 1991;133–6.
8.
Vasiljević jd: The role of endomyocardial biopsy in diagnosis and choice of treatment modalities in idiopathic and specific cardiomyopathies. review article. arch Balk Med Union. 2000;(2):95–106.
9.
Seferović P, Vasiljević Jd, Ostojić M. Komplikacije endomiokardne biopsije Kardiologija (Beograd). 1992;175–81.
10.
Vasiljevic M, Ha. Influence of pre-transplant myocarditis on post-transplant cardiac rejection episodes. Path research Pract. 1991;(6):778.
11.
Billingham ME: dilema of variety of hitopathologic grading systems for acute cardiac allograft rejection by endomyocardial biopsy. Heart Transplant. :272–6.
12.
Ha Jr M. Histologing grading of cardiac allograft rejection: a quantitative approach. j Heart Trasplant. 1990;277–82.
13.
Kemnitz J, Colnert T, H. a classification of cardiac allograft rejection. am j surg Parth. 1987;503–15.
14.
Vasiljević jd: The role of endomyocardial biopsy in the maintenance of cardiac transplant patients. Kardiologija (Belgrade). 1990;209–12.
15.
2003;328–36.
16.
report of the 1995 WHO -IsFC. Task Force on definition and Classification of Cardiomyopathies. Circulation. 1996;841–2.
17.
Maron B. Is the 2006 american Heart association classification of cardiomyopathies the gold standard? Circulation Heart Fail. 2008;72–6.
18.
Elliott P. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Europ Heart j. 2008;270–6.
19.
Thiene G, Basso C, C. Cardiomyopathies: is it time for a molecular classification? Europ Heart. 2004;1772–5.
20.
Mestroni L, Mlani. Clinical and pathologic study of familial dilated cardiomyopathy. am j Cardiol. 1990;1449–53.
21.
Vasiljević Jd, Kanjuh V, P, Egj O. diagnostic endomyocardial biopsy findings in 160 consecutive patients: the Yugoslavian experience. am j Cardiovasc Path. 1990;199–207.
22.
Seferović P, Maksimović R, Ostojić M, Vasiljević Jd. Myocardial catecholamines in primary heart muscle disease: fact or fancy? Europ Heart j. 1995;124–7.
23.
Olsen E. 1978;139–45.
24.
Vasiljević Jd, Mirić M, P. Endomyocardial biopsy findings in patients with hypertrophic cardiomyopathy. arch anat Cytol Path Clin Exp Path. 1998;328.
25.
Vasiljević Jd, Tucaković G, Mirić M. The role of endomyocardial biopsy in patients with hypertrophic cardiomyopathy. Virchow’s archive. 1999;343.
26.
Hr F. Idiopathic dilated Cardiomyopathy: Current Concepts in Clinical research. 1993;3–9.
27.
Kawai C, Matsumori A, Kitaura Y, Takatsu T. Viruses and the heart -viral myocarditis and cardiomyopathy. Prog in Cardiol. 1978;141–9.
28.
Hirshman S, Hammer G. Coxsackie virus myocarditis. a microbiological and clinical review. am j Cardiol. 1974;224–30.
29.
Ta M, Liu P, Petric M. Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. 1995;291–351.
30.
Richardson Pj. Wodak aa: alcohol-induced heart muscle disease. 1983;99–122.
31.
Vasiljević Jd, Kanjuh V, Šesto P, Ostojić M, Olsen E. The Incidence of Myocarditis in Endomyocardial Biopsy samples from Patients with Conjestive Heart Failure. Heart j. 1990;1370–7.
32.
Vasiljević Jd, Mirić M. Virusni miokarditis i dilataciona kardiomiopatija. Tersit (Izd). 1995;1–395.
33.
Brockington I, Egj O. Goodwin jF: Endomyocardial fibrosis in Europeans resident in tropical africa. Lancet. 1967;583.
34.
Oakley C, Egj O. Eosinophilia and heart disease. Br Heart j. 1977;223.
35.
Mm WP. Eosinophilic heart disease. 1983;24–32.
36.
Vasiljević Jd, Nedeljković V. Eosinophilic herat disease in children confirmed by endomyocardial biopsy. second Balkan Meeting of pediatric cardiology and cardiac surgery. sofia. 1994;55.
37.
Vasiljević, Đs, Cvejin B. Morphologic diagnosis of eosinophilic heart disease -biopsy and pathologic findings. 10th anniversary International symposium on Cardiovascular diseases, Novi sad. 1994;245.
38.
Thiene G, Corrado G, Basso C. arrhythmogenic right ventricular cardiomyopathy / dysplasia. Orphanet j rare dis. 2007;45.
39.
Thiene G, Basso C. arrhythmogenic right ventricular cardiomyopathy: an update. Cardiovasc Pathol. 2001;109–17.
40.
Vasiljević jd: seminar iz endomiokardne biopsije. VII Kongres patologa jugoslavije. Medicinski fakultet u Beogradu (Izd). 1996;1–22.
41.
Wenger N. specific heart muscle disease. 1985;108–15.
42.
Howell Rr. The glycogen storage diseases. 1982;149–52.
43.
Blieden L, Jh M. Cardiac involvement in inherited disorders of metabolism. Prog Cardiovasc dis. 1974;615–9.
44.
Vj F, Hibbs Rg B, Cd. The heart in Fabry, s disease. a histochemical and electron microscopic study. am j Cardiol. 1969;95–103.
45.
Mirić M, Vasiljević Jd. Imunske bolesti srca i krvnih sudova. Cicero (Izdavač). 2000;1–222.
46.
Vasiljević Jd, Popović Z, Vidaković M. Myocardial fibrosis assesment from semiquantitative, point-counting and computer-based methods: a comparative study. Histopatology. 2001;338–43.
47.
Buja L. Iron in the heart. Etiology and clinical significance. am j Med. 1971;209–15.
48.
Vasiljevic Jd, Kanjuh V, Tucakovic G. Myocardial lesion in idiopathic hema-chromatosis : Findings in 2 autopsied cases and 2 endomyocardial biopsy specimens. Path res Pract. 1989;(1):168.
49.
Roberts W, Ha M. Ferrans Vj: sarcoidosis of the heart. a clinicopathologic study of 35 necropsy patients and review of 78 previously described necropsy patients. am j Med. 1977;86–98.
50.
Fauci As, Haynes B, Katz P. The spectrum of vasculitis : Clinical, pathologic, immunologic and therapeutic considerations. ann Intern Med. 1978;660–9.
51.
Ma F, Mj B, Billingham M. rider aK: doxorubicin cardiotoxicity. serial endomyocardial biopsies and systolic time intervals. j am Med assoc. 1978;1603–11.
52.
Vasiljević jd: Uloga endomiokardne biopsije srca u dijagnostici primarnih bolesti srčanog mišića. MaG Medic (Beograd). 1995;(2):9.
53.
Ht, Billingham M, Wd E. Myocarditis / a histopathologic definition and classification. am j Cardiovasc Pathol. 1986;3–14.
54.
Maisch B, Herzum M. Immunomodulating factors and immunosuppressive drugs in the therapy of myocarditis. scand j Infect dis. 1993;149–62.
55.
Mirić M, Brkić, Vasiljević Jd. Long-term follow-up of patients with myocarditis and idiopathic dilated cardiomyopathy after immunomodulatory therapy. FEMs Immunology and Medical Microbiology. 1994;65–74.
56.
Mirić M, Vasiljević Jd, Bojić M. Long term follow-up of patients with dilated heart muscle disease treated with human leucocytic interferon-alpha or thymic hormones. Initial results. 1996;596–601.
57.
Vasiljević Jd, Otasevic P, Popovic Z. semi-quantitaitve Histomorphometric analysis of myocardium following partial left ventriculectomy: One-year follow-up. Europ j Heart Failure. 2005;763–7.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
